September MIMS update

Some of the recent changes to the medicines landscape, with new products, indications and contraindications  New Products • Albutrepenonacog alfa (Idelvion) is a recombinant fusion protein linking recombinant coagulation factor IX (FIX) with recombinant albumin that effectively replaces the missing coagulation FIX needed for haemostasis and provides for longer dose regimens. The prolongation of the